Direkt zum Inhalt
Merck
Alle Fotos(1)

Key Documents

View All Documentation

D0940

Sigma-Aldrich

p-Xylen-bis(N-Pyridiniumbromid)

≥95% purity (TLC), powder

Synonym(e):

DPX

Anmeldenzur Ansicht organisationsspezifischer und vertraglich vereinbarter Preise
Alle Fotos(1)

About This Item

Empirische Formel (Hill-System):
C18H18Br2N2
CAS-Nummer:
14208-10-7
Molekulargewicht:
422.16
MDL-Nummer:
MFCD00043749
UNSPSC-Code:
12171500
PubChem Substanz-ID:
329798653
NACRES:
NA.47

product name

p-Xylen-bis(N-Pyridiniumbromid), ≥95% (TLC)

Qualitätsniveau

100

Assay

≥95% (TLC)

Form

powder

Farbe

white to off-white

Löslichkeit

H2O: 1 mg/mL

εmax

8.6-9.2 at 256-262 nm in water

Anwendung(en)

diagnostic assay manufacturing
hematology
histology

Lagertemp.

2-8°C

SMILES String

[Br-].[Br-].C(c1ccc(C[n+]2ccccc2)cc1)[n+]3ccccc3

InChI

1S/C18H18N2.2BrH/c1-3-11-19(12-4-1)15-17-7-9-18(10-8-17)16-20-13-5-2-6-14-20;;/h1-14H,15-16H2;2*1H/q+2;;/p-2

InChIKey

MMKBQSJLLGHVIM-UHFFFAOYSA-L

Biochem./physiol. Wirkung

Cationic fluorescence quencher used with ANTS to study membrane permeability and liposome lysis.

Piktogramme

Exclamation mark
GHS07

Signalwort

Warning

Gefahreneinstufungen

Eye Irrit. 2 - Skin Irrit. 2 - STOT SE 3

Zielorgane

Respiratory system

Lagerklassenschlüssel

11 - Combustible Solids

WGK

WGK 3

Persönliche Schutzausrüstung

dust mask type N95 (US), Eyeshields, Gloves

Hier finden Sie alle aktuellen Versionen:

Analysenzertifikate (COA)

Lot/Batch Number
MKCT0130
MKCT5543
MKCQ5909
MKCM2060
MKCP9635

Die passende Version wird nicht angezeigt?

Wenn Sie eine bestimmte Version benötigen, können Sie anhand der Lot- oder Chargennummer nach einem spezifischen Zertifikat suchen.

Suche nach COA

Besitzen Sie dieses Produkt bereits?

In der Dokumentenbibliothek finden Sie die Dokumentation zu den Produkten, die Sie kürzlich erworben haben.

Die Dokumentenbibliothek aufrufen

Elisabeth B Thubron et al.
Scientific reports, 9(1), 11386-11386 (2019-08-08)
Diabetes increases the risk of Alzheimer's disease (AD), and mitochondrial dysfunction is implicated in both diseases, however the impact of both diabetes and AD on brain mitochondria is not known. We measured mitochondrial DNA (mtDNA), an indicator of mitochondrial function
Carolyn J Crandall et al.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, 34(8), 1419-1427 (2019-03-29)
We examined among women aged ≥40 years the performance of the Fracture Risk Assessment Tool (FRAX) and FRAX-based osteoporosis treatment thresholds under the US National Osteoporosis Foundation (NOF) and UK National Osteoporosis Guideline Group (NOGG) guidelines. We used registry data
Jennifer A Ross et al.
Brain structure & function, 224(7), 2385-2405 (2019-06-30)
A culmination of evidence from the literature points to the Locus Coeruleus (LC)-Norepinephrine system as an underappreciated and understudied area of research in the context of Alzheimer's Disease (AD). Stress is a risk factor for developing AD, and is supported
Elusa Cristina Oliveira et al.
Biology of reproduction, 100(3), 737-744 (2018-10-09)
Neonatal exposure to high-dose 17β-estradiol (E2) affects the morphology and physiology of sex and accessory sex organs in the long term. In this study, we examined the effects of E2 imprinting on male sexual behavior, fertility, and the number of
Dongxi Xiang et al.
Theranostics, 5(10), 1083-1097 (2015-07-23)
Insufficient penetration of therapeutic agents into tumor tissues results in inadequate drug distribution and lower intracellular concentration of drugs, leading to the increase of drug resistance and resultant failure of cancer treatment. Targeted drug delivery to solid tumors followed by
Alle zugehörigen Dokumente anzeigen

Unser Team von Wissenschaftlern verfügt über Erfahrung in allen Forschungsbereichen einschließlich Life Science, Materialwissenschaften, chemischer Synthese, Chromatographie, Analytik und vielen mehr..

Setzen Sie sich mit dem technischen Dienst in Verbindung.